Skip to main content
Home
Latest news
Browse topics
Lupus Rheumatoid arthritis Spondyloarthropathies COVID-19 Browse all topics
In focus
Bimekizumab: Dual IL-17A/IL-17F inhibition in SpA Anifrolumab for the treatment of SLE JAK inhibitor safety: Weighing up the data and understanding the risks Rituximab and rheumatology practice in the COVID-19 era Safety snapshot: Upadacitinib in patients with PsA Repurposing rheumatology drugs for COVID-19 Telemedicine in rheumatology: COVID-19 and beyond Managing PsA in resource-limited settings
Conferences
ACR Convergence 2022 EULAR 2022 Congress
About us
Medicine Matters Rheumatology
EXTENDED SEARCH
17 search results for:

Chondroitin sulfate 

sort by |
"newest" sorts results by publication date. "most relevant" also considers factors like how often the search phrase is in the result.
  1. 05-06-2017 | Osteoarthritis | News | Article

    Chondroitin sulfate as good as celecoxib for knee OA

    Results of a randomized trial suggest that pharmaceutical-grade chondroitin sulfate is as effective as the non-steroidal anti-inflammatory drug celecoxib for reducing pain and improving function among patients with symptomatic knee osteoarthritis.

    Published in:
    Ann Rheum Dis 2017; Advance online publication
  2. 11-06-2018 | Osteoarthritis | Article

    Effect of glucosamine and chondroitin sulfate in symptomatic knee osteoarthritis: A systematic review and meta-analysis of randomized placebo-controlled trials

    Although glucosamine and chondroitin sulfate have showed beneficial effects on joint tissues in osteoarthritis (OA), their therapeutic use in the

  3. 16-08-2021 | Temporal cell arteritis | Teaser

    New additions to the Adis Journal Club

    A monthly selection of topical peer-reviewed articles from the Adis journals, curated by the editors.

  4. 08-02-2022 | Temporal cell arteritis | Teaser

    Rituximab and rheumatology practice in the COVID-19 era

    How can rheumatologists respond to the challenges associated with rituximab use during the pandemic?

  5. 24-05-2021 | ACR 2021 | Teaser

    ACR Convergence 2021 highlights

    3–9 November: Keep up with the latest news and interviews from the conference.

  6. 06-09-2021 | Pneumonia | Teaser

    Anifrolumab for the treatment of lupus

    Perspective on the approval of anifrolumab and the importance of endpoints in lupus trials.

  7. 22-06-2021 | Osteoarthritis | News | Article

    NSAID use, limited physical activity linked to knee OA progression risk

    Simic and team analyzed data for 498 participants of the Long-term Evaluation of Glucosamine Sulfate study, in which individuals with chronic knee pain (≥4 on a scale of 0–10) and medial tibiofemoral narrowing (but retaining ≥2 mm of joint width) were randomly assigned to use glucosamine sulfate and/or chondroitin sulfate versus placebo for 2 years.

    Author:
    Laura Cowen
    Published in:
    Arthritis Res Ther 2021; 23 : 160
  8. 26-10-2020 | Vitamin D | Teaser

    Get ready for ACR Convergence 2020

    5 – 9 November: Preview the conference with session recommendations and updates on upcoming coverage.

  9. 10-05-2021 | Temporal cell arteritis | Teaser

    Febuxostat and cardiovascular risk in people with gout

    How will the FAST trial results impact regulatory guidance & clinical practice?

  10. 18-11-2020 | Temporal cell arteritis | Teaser

    Telemedicine in rheumatology

    Experts discuss the increasing use of telemedicine in rheumatology during the COVID-19 pandemic.

  11. 21-12-2018 | Osteoarthritis | News | Article

    Long-term impact unclear for knee OA medications

    Glucosamine sulfate was the only agent associated with a significant improvement in physical function (SMD=0.32) compared with placebo, while glucosamine sulfate, chondroitin sulfate, and strontium ranelate were significantly associated with reduced joint space narrowing (SMD=0.42, 0.20, and 0.20, respectively).

    Published in:
    JAMA 2018; 320 : 2564–2579
  12. 30-08-2018 | Osteoarthritis | News | Article

    Updated EULAR guidance for managing hand OA published

    They state that topical nonsteroidal anti-inflammatory drugs should be the first pharmacologic treatment option, while oral analgesics “should be considered for a limited duration for relief of symptoms,” and chondroitin sulfate may also be used to relieve pain and improve functioning.

    Published in:
    Ann Rheum Dis 2018; doi:10.1136/annrheumdis-2018-213826
  13. 28-08-2018 | Osteoarthritis | News | Article

    Oral OA therapy not linked to knee replacement risk

    Other oral treatments used by study participants were acetaminophen, glucosamine/chondroitin sulfate, narcotics, and cyclooxygenase-2 inhibitors.

    Published in:
    Arthritis Res Ther 2018; 20 : 172
  14. 04-09-2018 | Osteoarthritis | Highlight | Teaser
    medwireNews editor's pick

    Updated EULAR guidance for managing hand OA published

    EULAR has issued updated recommendations for the management of hand osteoarthritis based on current evidence and expert opinion.

  15. 28-08-2018 | Osteoarthritis | Article

    2018 update of the EULAR recommendations for the management of hand osteoarthritis

    Kloppenburg M et al. Ann Rheum Dis 2018. doi: 10.1136/annrheumdis-2018-213826

  16. 10-05-2018 | Osteoarthritis | Article

    A theory of planned behavior-based intervention to improve quality of life in patients with knee/hip osteoarthritis: A randomized controlled trial

    Saffari M et al. Clin Rheumatol 2018. doi: 10.1007/s10067-018-4120-4

  17. 30-04-2018 | Osteoarthritis | Article

    Effects of glucosamine in patients with osteoarthritis of the knee: A systematic review and meta-analysis

    Ogata T et al. Clin Rheumatol 2018; Advance online publication. doi: 10.1007/s10067-018-4106-2

  • 1

Filter search results

Search Operators:

„ ... ... “ Finds documents with exactly this word group, in exactly this word order and spelling (e.g., "employer branding").
AND Finds documents with both search terms (e.g., sales AND bonus).
OR Finds documents with one or the other search term (e.g., porsche OR volkswagen).
Blank Space Finds documents with all search terms. Blank space is understood as AND (e.g., man robot production).
NOT Finds documents with no appearance of the word behind NOT (e.g., ford NOT "harrison ford").
COUNT(...)>n Finds documents where the search term is mentioned at least "n" times."n" may be any number (e.g., COUNT(gear)>8).
NEAR(..., ..., ) Finds documents with both search terms in any word order, permitting "n" words as a maximum distance between them. Best choose between 15 and 30 (e.g., NEAR(recruit, professionals, 20)).
* Finds documents with the search term in word versions or composites. The star * marks whether you wish them BEFORE, BEHIND, or BEFORE and BEHIND the search term (e.g., lightweight*, *lightweight, *lightweight*).
? Finds documents with the search termn in different spellings."?" allows only one character (e.g., organi?ation).
& + - Special characters are understood as AND (e.g., Miller Bros. & Sons).

You can use operators in your search query to narrow down your results even more.

Tap the operator, or hover the mouse pointer over it, to read more about how it works.